Joe Schmidt

Co-Founder and President at Direct Biologics

[Joe Schmidt @ejschmidtgmail1]

Another One

https://t.co/hm8bOCbHTW

[Joe Schmidt @ejschmidtgmail1]

I am pleased to announce our partnership with Good Works II.

#Biotechnology #COVID19 #EVs

https://t.co/rXCpowHQaC

[BioInformant @StemCellMarket]

FDA Approves @DirectBiologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial - https://t.co/vJJklY4M1v

#exosomes #advancedtherapies

[Joe Schmidt @ejschmidtgmail1]

FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial

https://t.co/4LOPpu5pJ6

#covidー19 #covid19news #covid #ards #extracellularvesicles

[Joe Schmidt @ejschmidtgmail1]

FDA Grants Direct Biologics Regenerative Medicine Advanced Therapy (RMAT) Designation for the use of ExoFlo in COVID-19 Related ARDS

https://t.co/tD5D948ALg

#covid #covidー19 #extracellularvesicles #DirectBiologics #regenerativemedicine

[Joe Schmidt @ejschmidtgmail1]

Virginia mother reunited with newborn after going into COVID-induced coma

https://t.co/aAtEdNHNoF

#covid #covidー19 #covid19solutions #covid19news #extracellularvesicles

[Joe Schmidt @ejschmidtgmail1]

'Coming home': Alexandria police officer & mom reunites with her kids after COVID battle

https://t.co/IzM84vZzd1

[Joe Schmidt @ejschmidtgmail1]

Direct Biologics Reveals Successful Outcomes from EXIT COVID-19 Phase II Clinical Trial

#COVID19
#DirectBiologics
#EVs

https://t.co/xPJPKLE8L1

[Joe Schmidt @ejschmidtgmail1]

Happy Thanksgiving to you and your family and friends.

[Joe Schmidt @ejschmidtgmail1]

More than 30 battle wounded Navy seals, US congressmen, and Congressional Medal of Honor recepients were treated with a bone marrow mesenchymal stem cell (MSC) derived extracellular vesical isolate product (EVIP) for Osteoarthritis (OA). Learn more: https://t.co/Aqeld6WaEM.

[Joe Schmidt @ejschmidtgmail1]

Direct Biologics' protocol for the use of ExoFlo��� in the treatment of mild-to-moderate #COVID-19 represents the very first IND approved by the #FDA to investigate the use of extracellular vesicles (EVs) to treat mild-to-moderate COVID-19. #DirectBiologics

[Joe Schmidt @ejschmidtgmail1]

ExoFlo vs. COVID 19: https://t.co/SwIXjvaBKR

[Joe Schmidt @ejschmidtgmail1]

Direct Biologics Announces FDA Acceptance of IND Application for a Phase I/II Clinical Trial Studying ExoFlo for Acute Respiratory Distress Syndrome

https://t.co/m2xK97bqoA
#DirectBiologics

[Joe Schmidt @ejschmidtgmail1]

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19: https://t.co/CHrD2wVuVI. #DirectBiologics

[Joe Schmidt @ejschmidtgmail1]

Discover the newest generation of naturally bioactive products for regenerative therapies. Direct Biologics offers a platform of regenerative products, including extracellular vesicles and placental-based allografts: https://t.co/R2o9PiZLa8. #DirectBiologics #EVs

[Joe Schmidt @ejschmidtgmail1]

Learn about the treatment of idiopathic pulmonary fibrosis with an extracellular vesicle (EV) isolate product: https://t.co/vA5XL18k6e. #DirectBiologics

[Joe Schmidt @ejschmidtgmail1]

Post-acute #COVID-19 patients experience a broad range of long-lasting symptoms and other issues that preclude them from returning to prior baseline health and enjoying their daily lives. https://t.co/QhibTLvRD8. #DirectBiologics #ExoFlo #ExitCovid

[Joe Schmidt @ejschmidtgmail1]

Learn more about our therapies. Direct Biologics uses Mesenchymal Stem Cells (MSCs) - leading to the purest available regenerative treatment with zero reported adverse or safety effects. #WoundCare #COVID

[Joe Schmidt @ejschmidtgmail1]

Wishing everyone a happy and safe holiday! #DirectBiologics

[Joe Schmidt @ejschmidtgmail1]

Discover the newest generation of naturally bioactive products for regenerative therapies. Direct Biologics offers a platform of regenerative products, including extracellular vesicles and placental-based allografts: https://t.co/R2o9PiZLa8.
#EVs #DirectBiologics